Vivanza Biosciences Ltd.

VIVANZA

Market Cap
₹34 Cr.
P/E
39.35

Vivanza Biosciences Ltd.

Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Subscribe now for more updates
Forensics
Other Income
Other Income is not affecting ratios of the company
Pledge
Promoters have not pledged a significant portion of their holding
Revenue Recognition
Chances of aggressive revenue recognition - Operating profit of company is not getting converted to cash and recievables rising faster than sales
Depreciation Effect
Depreciation accounting is not leading to increase in profits
Capex vs ROCE
ROCE of the company has increased over the last three years
Retail Holding
Retail has been buying the stock which is usually a sign of exuberance
Share price
Share price has decreased over last 10 years more due to earnings
ROE
Financial Leverage has increased ROE over 10 years
Working Capital
Company has significant working capital which is dragging its ROCE and ROE
Debt
Company might have issues servicing its debt
Contingent Liabilities
Unable to calculate due to limited data
Promoter Holding
Promoters has been selling shares in the open market over last 90 days
Current vs Historic Valuation
Company is trading at a discount to 3 year historic valuations
ROE
Latest
14.63%
3yr Average
8.85%
5yr Average
1.29%
Net Profit Margin
Latest
3.36%
3yr Average
2.44%
5yr Average
-2.28%
ROCE
Latest
20.82%
3yr Average
17.45%
5yr Average
11.8%
Debt to Equity
Latest
1.95
3yr Average
1.22
5yr Average
0.84
Revenue mix

Product Wise Break-Up

Latest
|
locked
Historic
Show more
Company Filing
Show Previous Years
Discussions & Analysis
timeline